Eric Lederer is listed as an executive officer on 7 SEC Form D filings by 1 issuer between Oct 2013 and May 2018: Sonnet BioTherapeutics Holdings, Inc. (Princeton, NJ — biotechnology — 2013–2018; $6M reported sold to 193 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Michael D. Pruitt (7 shared filings), Russell J. Page (7 shared filings), Keith Johnson (5 shared filings), Michael Carroll (5 shared filings), Paul Moskowitz (5 shared filings) and 8 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Eric. Each name links to their own page.
The issuer belongs to the sponsor group Sonnet Biotherapeutics (2 issuers, $4.67M reported sold, 2011–2024).
What this means A sponsor group is one team that sets up a new company for each deal. Sonnet Biotherapeutics has 2 companies on file and $4.67M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 7 public filings for Eric Lederer and found 1 difference: No amendment in the last 12 months on an offering that may still be open.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.